EurekAlert! News by Subject: Medicine & Health - Home

Medicine & Health

Updates every hour. Last Updated: 20-Jun-2026 09:16 ET (20-Jun-2026 13:16 GMT/UTC)

UT Health San Antonio launches clinical trial to study rapamycin and healthy aging

The University of Texas at San Antonio Health Science Center
Business Announcement

UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio) is launching a multi-phase clinical study to better understand how the drug rapamycin may promote healthy aging. Funded by the National Institute on Aging, the study will examine dosing, safety and long-term effects to help guide future research on extending health span.

Surgical management and reconstruction strategies highlighted for head and neck basal cell carcinoma

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — March 26, 2026 — A new research perspective was published in Volume 13 of Oncoscienceon March 11, 2026, titled “Basal cell carcinoma of the head and neck: Surgical management and postoperative strategies – A researcher’s perspective.”

Journal: Oncoscience

Ependymoma fusion protein locks cells in developmental limbo

St. Jude Children's Research Hospital
Peer-Reviewed Publication

St. Jude Children’s Research Hospital and Baylor College of Medicine scientists show how ZFTA-RELA fusions hijack developmental programs to drive a type of pediatric brain cancer.

Journal: Nature

New medicine piggybacks onto fat absorption pathways to allow oral delivery and support clinical trial in major depressive disorder

Monash University
Peer-Reviewed Publication

Monash University and Seaport Therapeutics have developed a new approach to delivering drug molecules that piggybacks onto natural fat absorption pathways to allow oral delivery of some drugs previously requiring injection.

Journal: Science Translational Medicine

Largest clinical trial using brain training to reduce dementia receives $2.8 million in federal funding for USF

University of South Florida
Grant and Award Announcement

An expansive clinical trial led by University of South Florida researchers and aimed at delaying the onset of dementia continues to receive major federal support with an additional $2.8 million from the National Institutes of Health. The funding helps to continue research into whether computerized brain training exercises can reduce the risk of cognitive impairment and dementia such as Alzheimer’s disease. The Preventing Alzheimer’s with Cognitive Training (PACT) study has now received more than $50 million in federal grant funding.

Douglas P. Kiel, MD, MPH, elected to the Association of American Physicians

Hebrew SeniorLife Hinda and Arthur Marcus Institute for Aging Research
Business Announcement

Douglas P. Kiel, MD, MPH, a senior scientist and director of the Musculoskeletal Research Center at the Hinda and Arthur Marcus Institute for Aging Research at Hebrew SeniorLife, has been elected to membership in the Association of American Physicians, one of the nation’s most prestigious honorary medical societies. He is a professor of medicine at Harvard Medical School.

Center for BrainHealth forms groundbreaking research collaborative to enable data sharing, accelerate discovery

Center for BrainHealth
Business Announcement

Connecting researchers across the country, the BrainHealth Network launched in February 2026. The groundbreaking collaborative research initiative seeks to leverage advanced MRI imaging and data analysis from one of the most comprehensive multimodal brain imaging datasets ever assembled in order to understand brain health improvement.

Living in historically redlined neighborhoods may reduce one’s ability to conceive

Boston University School of Public Health
Peer-Reviewed Publication

New studies published in the American Journal of Epidemiology and Epidemiology found that people residing in redlined neighborhoods—neighborhoods that were subjected to the historic practice of mortgage lending discrimination by the federal government—were less likely to conceive than those who lived in neighborhoods the government deemed favorable for mortgage lending.

Journal: American Journal of Epidemiology

New study finds common blood pressure drug boosts cancer treatment

Dartmouth Health
Peer-Reviewed Publication

Researchers at Dartmouth Cancer Center, led by Tyler J. Curiel, MD, MPH, FACP, found that the common blood pressure medication telmisartan can significantly boost the effectiveness of the cancer drug olaparib, potentially expanding the therapy’s benefits to more patients and helping overcome treatment resistance.

Journal: Journal for ImmunoTherapy of Cancer
Funder: Dartmouth Cancer Center